Atika Capital Management LLC Cytokinetics Inc Transaction History

Atika Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$63.75 - $108.06 $1.21 Million - $2.05 Million	19,000 Added 37.25%	70,000 $4.91 Million
Q4 2023 Feb 13, 2024	BUY	$26.88 - $83.49 $1.37 Million - $4.26 Million	51,000 New	51,000 $4.26 Million
Q1 2023 May 12, 2023	BUY	$33.36 - $45.71 $302,341 - $414,269	9,063 Added 13.73%	75,063 $2.64 Million
Q4 2022 Feb 13, 2023	SELL	$35.77 - $51.11 $3.37 Million - $4.82 Million	-94,310 Reduced 58.83%	66,000 $3.02 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.28 Million - $1.82 Million	33,300 Added 26.22%	160,310 $7.77 Million
Q2 2022 Aug 12, 2022	BUY	$33.93 - $48.92 $4.31 Million - $6.21 Million	127,010 New	127,010 $4.99 Million

407

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.31B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.